Liu He Selected Research

Liu He Research Topics

Disease

15	Atrial Fibrillation 07/2022 - 04/2019
13	Neoplasms (Cancer) 01/2022 - 12/2008
8	Stroke (Strokes) 04/2022 - 06/2011
6	Alzheimer Disease (Alzheimer's Disease) 03/2021 - 03/2016
4	Heart Failure 01/2022 - 04/2019
3	Ischemic Stroke 01/2022 - 01/2021
2	Fibrosis (Cirrhosis) 07/2022 - 11/2015
2	Thromboembolism 04/2022 - 04/2019
2	Embolism (Embolus) 01/2022 - 05/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021 - 01/2021
2	Hemorrhage 08/2021 - 12/2020
2	Thyroid Neoplasms (Thyroid Cancer) 07/2021 - 01/2015
2	Wounds and Injuries (Trauma) 01/2021 - 01/2021
2	Colorectal Neoplasms (Colorectal Cancer) 09/2020 - 12/2008
2	Pain (Aches) 01/2020 - 10/2016
2	Breast Neoplasms (Breast Cancer) 10/2017 - 03/2016
2	Obesity 08/2017 - 06/2011
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2015 - 08/2015
2	Flushing 08/2015 - 11/2012
2	Type 2 Diabetes Mellitus (MODY) 09/2009 - 06/2009
1	Periodontitis 10/2022
1	Metabolic Bone Diseases (Osteopenia) 10/2022
1	Chronic Renal Insufficiency 07/2022
1	Rolandic Epilepsy (Centrotemporal Epilepsy) 05/2022
1	ST Elevation Myocardial Infarction 02/2022
1	Anemia 01/2022
1	Frailty 01/2022
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2021
1	Leiomyomatosis 07/2021
1	Disease Progression 07/2021
1	Carcinogenesis 07/2021
1	Residual Neoplasm 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Cognitive Dysfunction 01/2021
1	Glioma (Gliomas) 01/2021
1	Crush Injuries 01/2021
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2021
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 01/2022 - 04/2019
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2006
4	Neuroprotective AgentsIBA 01/2019 - 03/2016
3	LipidsIBA 04/2022 - 09/2009
3	Biological ProductsIBA 01/2022 - 01/2018
3	CholesterolIBA 01/2021 - 06/2011
3	Anti-Arrhythmia AgentsIBA 01/2021 - 06/2019
3	InflammasomesIBA 11/2019 - 01/2018
3	Heparin (Liquaemin)FDA LinkGeneric 03/2016 - 11/2012
2	CytokinesIBA 10/2022 - 11/2015
2	oxidized low density lipoproteinIBA 04/2022 - 01/2021
2	LDL CholesterolIBA 04/2022 - 01/2021
2	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 04/2019
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 07/2020
2	Pharmaceutical PreparationsIBA 01/2022 - 11/2019
2	ChitosanIBA 10/2021 - 01/2021
2	Therapeutic UsesIBA 01/2021 - 10/2016
2	N(4)-oleylcytosine arabinosideIBA 01/2021 - 04/2019
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 09/2009
2	HDL CholesterolIBA 01/2021 - 06/2011
2	Sodium Chloride FDA LinkGeneric 08/2015 - 11/2012
2	Saline SolutionIBA 08/2015 - 11/2012
2	SolutionsIBA 08/2015 - 11/2012
1	Hypoxia-Inducible Factor 1IBA 10/2022
1	GadoliniumIBA 07/2022
1	Mineralocorticoid Receptor AntagonistsIBA 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022
1	Angiotensin Receptor AntagonistsIBA 01/2022
1	RNA Polymerase IIIIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	poly(lactide) (polylactic acid)IBA 10/2021
1	diazonaphthalenedisulfonic acid (NDS)IBA 10/2021
1	Hemostatics (Antihemorrhagics)IBA 08/2021
1	ulipristal acetate FDA Link 07/2021
1	Goserelin (Zoladex)FDA Link 07/2021
1	Tamoxifen FDA LinkGeneric 07/2021
1	Death-Associated Protein KinasesIBA 07/2021
1	TNF-Related Apoptosis-Inducing LigandIBA 07/2021
1	TESIBA 05/2021
1	CurcuminIBA 03/2021
1	ParaffinIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	ChitinIBA 01/2021
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Contrast MediaIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	LigandsIBA 01/2021
1	LactoferrinIBA 01/2021
1	Amiodarone (Amiodarona)FDA LinkGeneric 12/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020

Therapy/Procedure

5	Catheter Ablation 07/2022 - 01/2021
5	Therapeutics 01/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2022 - 10/2021
2	Radiofrequency Ablation 01/2022 - 09/2020
2	Neoadjuvant Therapy 10/2017 - 08/2017
1	Transcranial Magnetic Stimulation 05/2022
1	Percutaneous Coronary Intervention 02/2022
1	Electric Countershock (Cardioversion) 08/2021
1	Local Anesthesia 01/2021